|
| |
| | | 67661 | | 04.03.2021 | | Sanofi-Aventis (Suisse) SA | | | | | | | | | | | | | 07.15. | | | | 07.15. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Dupixent 200 mg/ 1.14 ml | solution injectable en stylo pré-rempli | solution injectable en stylo pré-rempli (Dupilumabum 200mg / 1.14ml) | D11AH05 | CI | | 02 | Dupixent 300 mg/ 2 ml | solution injectable en stylo pré-rempli | solution injectable en stylo pré-rempli (Dupilumabum 300mg / 2ml) | D11AH05 | CI |
|
|
|
